Amgen settles with Coherus over arthritis treatment

28-11-2019

Saman Javed

Amgen settles with Coherus over arthritis treatment

g0d4ather / Shutterstock.com

Amgen and Coherus Biosciences have settled a patent infringement dispute, after Coherus claimed that Amgen was infringing three of its patents.


US District Court for the District of Delaware, Coherus Biosciences, Amgen, patent infringement, biosimilar, arthritis

LSIPR